Clariane SE (LON:0OPS)
London · Delayed Price · Currency is GBP · Price in EUR 3.624
-0.124 (-3.32%)
At close: Dec 12, 2025
Clariane SE Market Cap
Clariane SE has a market cap or net worth of 1.12 billion as of December 15, 2025. Its market cap has increased by 115.93% in one year.
Market Cap
1.12B
Enterprise Value
7.97B
Revenue
4.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
3.62
Market Cap Chart
Since November 24, 2006, Clariane SE's market cap has increased from 527.71M to 1.12B, an increase of 113.02%. That is a compound annual growth rate of 4.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 1.12B | 82.62% |
| Dec 31, 2024 | 614.59M | 175.90% |
| Dec 29, 2023 | 222.76M | -76.49% |
| Dec 30, 2022 | 947.41M | -61.61% |
| Dec 31, 2021 | 2.47B | -16.31% |
| Dec 31, 2020 | 2.95B | 0.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.48B |
| GSK plc | 73.26B |
| Haleon | 31.93B |
| Smith & Nephew | 10.33B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.36B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.67B |